ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EC Healthcare Acquires Hong Kong Dental Services Chain

HONG KONG, Nov 30, 2021 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into an agreement to acquire 55% of the issued share capital of Bayley & Jackson Dental Surgeons Limited (the "Target Company"), for a total consideration of approximately HK$129 million, which shall be satisfied as to approximately HK$ 119 million in cash and as to approximately HK$10 million by the allotment and issue of Consideration Shares at HK$ 12.557 per share.

The Target Company is a dental services chain operator with a long-standing history in Hong Kong providing dental services in Hong Kong since 1958. As of the date of this announcement, the Target Company operates seven dental clinics located in Central, Tsim Sha Tsui, Mong Kok, Repulse Bay and Clean Water Bay of Hong Kong with 32 practicing dentists including dental general practitioners and specialists. According to the unaudited financial information for the year ended 31 March 2021, the profit after tax of the Target Company amounted to HK$15.18 million. Upon completion of the acquisition, the financial result of the Target Company will be consolidated into the consolidated financial statement of the Group. The Target Company guarantees to the Group with an aggregate net profit for the seven financial years ending 31 March 2029 should be no less than HK$120 million.

The Target Company has long-standing history, unique and well recognized brand and owns an extensive loyal corporate client base serving companies such as The Hong Kong Polytechnic University, Cathay Pacific Airways Limited and MTR Corporation Limited. Leveraging on its operational excellence and efficiencies, the Group will benefit from the Target Company's brand equity and continue to empower the Group's existing dental-related medical assets, improve the overall efficiency of the Group's dental medical assets and enhance the service capability as a multi-specialty medical service provider, thus further enhancing the customer retention rate and the overall profitability of the Group.

Mr. Levin Lee, Executive Director and Chief Finance Officer of EC Healthcare said, "This acquisition will help expand the Group's existing dental business, deepen and enhance the service capability of the Group's medical services segment, thereby further strengthening its leadership in the discretionary medical market. Looking ahead, the Group will be well-positioned to continue exploiting the reciprocal business interaction between dental and medical aesthetic businesses to create more value. Meanwhile, the Group will complement with advancement in information technology, branding, and service to build the enclosed healthcare ecosystem and to further consolidate the healthcare market."

About EC Healthcare
EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020

For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Charmaine Ip
Tel: (852) 2136 6952 / 2169 0467 / 3920 7649
Fax: (852) 3170 6606
Email: ech@iprogilvy.com



Source: EC Healthcare

Copyright 2021 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.